Comparing intravenous and oral antibiotics for acute infections
Official title: Intravenous Versus Oral Treatment of the Main Acute Infections in Emergency Departments
Run by University of Southern Denmark · NCT06715306 · Data updated 2026-11-12
This study tests if oral antibiotics can work just as well as intravenous ones for people in the hospital with acute infections to see if they can shorten hospital stays and lower risks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 4000 (estimated) |
| Sponsor | University of Southern Denmark Academic / other |
| Locations | 7 sites (Aabenraa, Southern Denmark and 6 other locations) |
| Status | Recruiting |
| Started | January 15, 2025 |
| Main results expected | January 6, 2027 |
| Study ends | January 6, 2028 |
| Registry record updated | March 5, 2026 |
| Trial ID | NCT06715306 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients admitted with suspected respiratory tract infections, urinary tract infections, or cellulitis who are planned to receive intravenous antibiotics.
✕Probably not a fit
Patients who have received more than two doses of intravenous antibiotics or have severe health conditions requiring immediate intravenous treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the safety and efficacy of oral antibiotic regimens compared to standard intravenous antibiotic treatment in patients admitted to the hospital with acute infections such as respiratory tract infections, urinary tract infections, and cellulitis. Participants will be randomly assigned to receive either intravenous antibiotics or tailored oral antibiotics based on microbiological recommendations. The goal is to determine if oral antibiotics can effectively replace intravenous treatment, potentially reducing hospital stays and associated risks. The study is designed as an open-label, prospective, randomized controlled trial.
Why it matters
Potential benefit: If successful, this approach could lead to shorter hospital stays and reduced healthcare costs for patients with acute infections.
How similar studies have gone: Previous studies have explored the use of oral antibiotics in similar contexts, showing promising results, but this specific approach is still being tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Suspected respiratory tract infection, urinary tract infection, or cellulitis by the attending physician * Planned or initiated intravenous antibiotic treatment Exclusion Criteria: * if received more than two doses of intravenous antibiotics; * systolic blood pressure \<90 mmHg; * nausea and/or vomiting in more than one short-term instance during the last 2 days; * suspected significantly reduced gastrointestinal absorption; * confirmed plasma-lactate \> 2; * pregnant or nursing; * unable to give informed consent; * severe immunodeficiency; * urgent vital treatment needed.
Where it's running
-
Sygehus Sønderjylland
Aabenraa, Southern Denmark, Denmark Recruiting -
Nordsjællands Hospital
Copenhagen, Denmark Recruiting -
Esbjerg and Grindsted Sygehus
Esbjerg, Denmark Recruiting -
Sygehus Lillebælt
Kolding, Denmark Recruiting -
Bispebjerg and Frederiksberg Hospital
Copenhagen, Denmark Active not recruiting -
Herlev and Gentofte Hospital
Herlev, Denmark Active not recruiting
Show 1 more location
-
Amager and Hvidovre Hospital
Hvidovre, Denmark Active not recruiting
Study contacts
- Study coordinator: Mariana Bichuette Cartuliares
- Email: mbc@rsyd.dk
- Phone: +45 79971113
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Stop antibiotics early when symptoms stop in kids after IV treatment
This trial tests whether stopping oral antibiotics as soon as symptoms disappear is just as effective as finishing the prescribed course for kids who had IV antibiotics for cellulitis, UTI, LRTI, or lymphadenitis.
-
Testing single and multiple IV doses of JKN2501 in healthy Chinese adults
This test gives single and multiple intravenous doses of JKN2501 to healthy Chinese adults to see if it's safe and how the body processes it.
-
Families' views on antibiotic length and using a smartwatch to track children's symptoms
We will see if families are comfortable with shorter antibiotic courses and if a Garmin smartwatch can help track symptoms in children aged 4–17 with uncomplicated infections.
-
Using fosfomycin to treat severely infected patients
This study is testing if an intravenous antibiotic called fosfomycin can safely help people with serious infections like osteomyelitis and bacterial meningitis feel better.
-
Baloxavir for preventing flu after exposure in household contacts
A single dose of baloxavir marboxil is being tested to see if it prevents symptomatic, lab-confirmed influenza in people who live with someone who has flu symptoms.
-
Gentamicin Irrigation and Suction Ureteral Access in Kidney Stone Surgery
This trial tests whether using gentamicin-containing irrigation fluid and a suction-enabled ureteral access sheath during retrograde intrarenal surgery (RIRS) can lower fever, SIRS, and sepsis after kidney stone treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.